We have located links that may give you full text access.
Psoriasis management in actual clinical practice: a 6-year retrospective study of 845 patients.
Journal of Dermatological Treatment 2018 May 8
BACKGROUND: Over the past years, with the availability of relatively well tolerated, very effective but expensive drugs, biologics, treatment of psoriasis has dramatically shifted from inpatient modalities to outpatient ones. Relatively little is known about true life practices regarding psoriasis treatment in our country.
AIMS: To assess the impact of introduction of conventional drugs and biological drugs on medical resource use of psoriasis patients.
STUDY DESIGN: A retrospective chart review was performed.
METHODS: Patients with the diagnosis of psoriasis who were seen in the period between 2010 and 2015 were included in the study. Data including hospital resource use (inpatient, outpatient, day ward) and treatment modalities were collected.
RESULTS: The study population comprised 845 patients with 1053 different treatment modalities. There was not any significant difference between number of in-hospital days and frequency of hospitalization between biological drugs and cyclosporine. There was significant (p < .05) decline in the length of hospitalization after the year 2012 in biological treatment group.
CONCLUSIONS: Treatment of MSP with classical drugs requires fairly similar medical resource expenditures as biologics.
AIMS: To assess the impact of introduction of conventional drugs and biological drugs on medical resource use of psoriasis patients.
STUDY DESIGN: A retrospective chart review was performed.
METHODS: Patients with the diagnosis of psoriasis who were seen in the period between 2010 and 2015 were included in the study. Data including hospital resource use (inpatient, outpatient, day ward) and treatment modalities were collected.
RESULTS: The study population comprised 845 patients with 1053 different treatment modalities. There was not any significant difference between number of in-hospital days and frequency of hospitalization between biological drugs and cyclosporine. There was significant (p < .05) decline in the length of hospitalization after the year 2012 in biological treatment group.
CONCLUSIONS: Treatment of MSP with classical drugs requires fairly similar medical resource expenditures as biologics.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app